Chenrong Huang

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

Liyan Miao, Jian Yang, Chenrong Huang et al. · European Journal of Clinical Pharmacology · 2007 · 190 citations

Metabolic Syndrome, Thrombosis, Venous Thrombosis +14

Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects

Yicong Bian, Hua Zhang, Sheng Ma et al. · British Journal of Clinical Pharmacology · 2020 · 168 citations

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

Yan Wang, Haiqing Ni, Shuaixiang Zhou et al. · Cancer Immunology Immunotherapy · 2020 · 103 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +10

First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform

Jun Cao, Yijun Mi, Cuilin Shi et al. · Biochemical and Biophysical Research Communications · 2018 · 54 citations

Novel Mechanism, Pulmonary Tuberculosis, Biochemistry +13

Theory‐based pharmacokinetics and pharmacodynamics of S‐ and R‐warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients

Ling Xue, Xiaoliang Ding, Zhenya Shen et al. · British Journal of Clinical Pharmacology · 2016 · 45 citations · Full text